Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

APO Medical Opportunities

+ Add to Watchlist

APOMOPP:LX

124.08 EUR 0.90 0.72%

As of 00:59:30 ET on 03/04/2015.

Snapshot for APO Medical Opportunities (APOMOPP)

Year To Date: +8.05% 3-Month: +8.04% 3-Year: +22.83% 52-Week Range: 99.15 - 125.10
1-Month: +4.94% 1-Year: +17.84% 5-Year: +16.47% Beta vs LUXXX: 0.59

Mutual Fund Chart for APOMOPP

No chart data available.
  • APOMOPP:LX 124.08
  • 1M
  • 1Y
Interactive APOMOPP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for APOMOPP

APO Medical Opportunities is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equities of companies from the health care sector.

Inception Date: 08-31-2005 Telephone: 352-260248-1 Tel
Managers: KAI BRUENING / HARALD SCHWARZ
Web Site: www.ipconcept.lu

Fundamentals for APOMOPP

NAV (on 2015-03-04) 124.08
Assets (M) (on 2015-03-04) 185.74
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for APOMOPP

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for APOMOPP

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 0.57
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.96

Top Fund Holdings for APOMOPP

Filing Date: 01/31/2015
Name Position Value % of Total
Novartis AG 70,737 6,143,265 3.440%
Bayer AG 32,835 4,196,707 2.350%
Abbott Laboratories 96,379 3,821,683 2.140%
Edwards Lifesciences Corp 30,716 3,410,941 1.910%
BioMarin Pharmaceutical Inc 39,421 3,393,083 1.900%
Roche Holding AG 13,870 3,321,649 1.860%
Amgen Inc 23,957 3,214,499 1.800%
Sanofi 37,459 3,071,633 1.720%
Pfizer Inc 104,773 2,875,191 1.610%
WuXi PharmaTech Cayman Inc 77,919 2,768,041 1.550%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil